Rani Therapeutics Inc. (RANI)
NASDAQ: RANI
· Real-Time Price · USD
0.55
-0.01 (-1.22%)
At close: Aug 15, 2025, 3:58 PM
Rani Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.22M | -7.26M | -15.72M | -12.72M | -6.8M | -7.48M | -7.1M | -18.33M | -18.66M | -16.83M | -17.34M | -16.21M | -15.97M | -13.83M | -13.3M | -28.7M | -5.49M | -5.6M |
Depreciation & Amortization | 240K | 251K | 266K | 259K | 255K | 248K | 227K | 218K | 189K | 188K | 174K | 141K | 122K | 111K | 113K | 120K | 128K | 136K |
Stock-Based Compensation | 3.29M | 3.92M | 3.99M | 4.04M | 4.13M | 3.87M | 4.49M | 4.97M | 5.14M | 4.42M | 4.5M | 4.4M | 3.98M | 2.9M | 3.16M | 18.7M | 282K | 453K |
Other Working Capital | -90K | 39K | -925K | -1.72M | 381K | 1M | -2.33M | -1.26M | 1.67M | 380K | -1.4M | -721K | 1.25M | 1.22M | -1.29M | -2.26M | -716K | 293K |
Other Non-Cash Items | 680K | -5.09M | 3.94M | 668K | -6.69M | -7.2M | -1.5M | 318K | 318K | -381K | -347K | 20K | 160K | 157K | 1K | -16K | 57K | 67K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -5.6M | -609K | -543K | n/a | n/a | n/a | n/a | n/a | n/a | 785K | 70K | 216K |
Change in Working Capital | 1.22M | 28K | -1.13M | -656K | 81K | 1.16M | -2.99M | -864K | 1.26M | 456K | -1.61M | -553K | 1.38M | 1.29M | -1.42M | -2M | -680K | 678K |
Operating Cash Flow | -5.8M | -8.15M | -8.65M | -8.41M | -9.03M | -9.4M | -12.48M | -14.3M | -12.3M | -12.15M | -14.63M | -12.2M | -10.33M | -9.36M | -11.45M | -11.12M | -5.63M | -4.05M |
Capital Expenditures | -37K | -51K | -31K | -125K | -94K | -18K | -167K | -479K | -335K | -248K | -530K | -456K | -379K | -254K | -271K | n/a | -136K | -99K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -13.44K | -12.15K | -1.12K | n/a | -71.74M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -8K | -2.72M | -17.75M | -19.05M | -11.58M | -10.04M | -9.41M | -11.35M | -33.88M | -18.63M | -2.93M | -70.89M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 5.75M | 21M | 20.3M | 18.7M | 18.2M | 20.35M | 22.85M | 23.5M | 35M | 23M | 3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 8K | n/a | n/a | 940K | n/a | n/a | 13.44K | 12.15K | 1.12K | n/a | 71.74M | -70.89K | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 5.71M | 18.23M | 2.52M | 469K | 6.53M | 10.29M | 13.27M | 11.67M | 789K | 4.12M | -457K | -71.35M | -379K | -254K | -271K | n/a | -136K | -99K |
Debt Repayment | -3.75M | -3.75M | -3.75M | -1.25M | n/a | n/a | n/a | n/a | n/a | n/a | 14.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 46K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9 | n/a | n/a | -626 | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -8K | -23K | -10K | -14K | -24K | n/a | n/a | -29K | 80K | 8K | -29K | 14.08M | 49K | n/a | n/a | 71.55M | -1.58M | 1.43M |
Financial Cash Flow | 188K | -3.73M | 5.62M | 7.7M | 141K | 121K | 96K | 49K | 80.00 | 8K | 14.87M | 14.08M | 49K | n/a | -570K | 71.55M | -1.58M | 7.75M |
Net Cash Flow | 105K | 6.35M | -515K | -237K | -2.36M | 1.01M | 892K | -2.58M | -11.43M | -8.02M | -212K | -69.46M | -10.66M | -9.61M | -12.29M | 60.43M | -7.35M | 3.6M |
Free Cash Flow | -5.83M | -8.2M | -8.69M | -8.54M | -9.12M | -9.42M | -12.64M | -14.78M | -12.64M | -12.4M | -15.16M | -12.65M | -10.71M | -9.61M | -11.72M | -11.12M | -5.76M | -4.15M |